Based on the analysis of Johnson Johnson's profitability, liquidity, and operating efficiency, Johnson Johnson is doing better financially today then in previous quarter. It has a moderate probability of reporting better financial numbers in October. At this time, Johnson Johnson's Net Debt is relatively stable compared to the past year. Retained Earnings is expected to hike to about 161.5 B this year, although the value of Cash And Short Term Investments will most likely fall to nearly 14.3 B. Key indicators impacting Johnson Johnson's financial strength include:
The financial analysis of Johnson Johnson is a critical element in measuring its lifeblood. Investors should not minimize Johnson Johnson's ability to pay suppliers or employees on time, ensuring interest payments are not accumulating.
Cash And Equivalents
3.1 Billion
Johnson
Select Account or Indicator
Market Cap
Enterprise Value
Price To Sales Ratio
Dividend Yield
Ptb Ratio
Days Sales Outstanding
Book Value Per Share
Free Cash Flow Yield
Operating Cash Flow Per Share
Stock Based Compensation To Revenue
Capex To Depreciation
Pb Ratio
Ev To Sales
Free Cash Flow Per Share
Roic
Inventory Turnover
Net Income Per Share
Days Of Inventory On Hand
Payables Turnover
Research And Ddevelopement To Revenue
Capex To Revenue
Cash Per Share
Pocfratio
Interest Coverage
Payout Ratio
Capex To Operating Cash Flow
Pfcf Ratio
Days Payables Outstanding
Income Quality
Roe
Ev To Operating Cash Flow
Pe Ratio
Return On Tangible Assets
Ev To Free Cash Flow
Earnings Yield
Intangibles To Total Assets
Net Debt To E B I T D A
Current Ratio
Tangible Book Value Per Share
Receivables Turnover
Graham Number
Shareholders Equity Per Share
Debt To Equity
Capex Per Share
Graham Net Net
Revenue Per Share
Interest Debt Per Share
Debt To Assets
Enterprise Value Over E B I T D A
Short Term Coverage Ratios
Price Earnings Ratio
Operating Cycle
Price Book Value Ratio
Price Earnings To Growth Ratio
Days Of Payables Outstanding
Dividend Payout Ratio
Price To Operating Cash Flows Ratio
Price To Free Cash Flows Ratio
Pretax Profit Margin
Ebt Per Ebit
Operating Profit Margin
Effective Tax Rate
Company Equity Multiplier
Long Term Debt To Capitalization
Total Debt To Capitalization
Return On Capital Employed
Debt Equity Ratio
Ebit Per Revenue
Quick Ratio
Dividend Paid And Capex Coverage Ratio
Net Income Per E B T
Cash Ratio
Cash Conversion Cycle
Operating Cash Flow Sales Ratio
Days Of Inventory Outstanding
Days Of Sales Outstanding
Free Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage Ratios
Price To Book Ratio
Fixed Asset Turnover
Capital Expenditure Coverage Ratio
Price Cash Flow Ratio
Enterprise Value Multiple
Debt Ratio
Cash Flow To Debt Ratio
Price Sales Ratio
Return On Assets
Asset Turnover
Net Profit Margin
Gross Profit Margin
Price Fair Value
Return On Equity
Sale Purchase Of Stock
Change To Inventory
Change In Cash
Free Cash Flow
Change In Working Capital
Begin Period Cash Flow
Other Cashflows From Financing Activities
Depreciation
Dividends Paid
Capital Expenditures
Total Cash From Operating Activities
Net Income
Total Cash From Financing Activities
End Period Cash Flow
Other Non Cash Items
Change To Account Receivables
Other Cashflows From Investing Activities
Change To Liabilities
Stock Based Compensation
Investments
Change Receivables
Net Borrowings
Total Cashflows From Investing Activities
Exchange Rate Changes
Cash And Cash Equivalents Changes
Cash Flows Other Operating
Change To Netincome
Change To Operating Activities
Total Assets
Short Long Term Debt Total
Other Current Liab
Total Current Liabilities
Total Stockholder Equity
Property Plant And Equipment Net
Net Debt
Retained Earnings
Cash
Non Current Assets Total
Non Currrent Assets Other
Cash And Short Term Investments
Net Receivables
Common Stock Shares Outstanding
Liabilities And Stockholders Equity
Non Current Liabilities Total
Inventory
Other Current Assets
Other Stockholder Equity
Total Liab
Total Current Assets
Short Term Debt
Intangible Assets
Accounts Payable
Common Stock Total Equity
Short Term Investments
Property Plant And Equipment Gross
Accumulated Other Comprehensive Income
Capital Stock
Common Stock
Other Liab
Other Assets
Long Term Debt
Good Will
Treasury Stock
Property Plant Equipment
Current Deferred Revenue
Net Tangible Assets
Total Permanent Equity
Retained Earnings Total Equity
Long Term Debt Total
Deferred Long Term Liab
Non Current Liabilities Other
Deferred Long Term Asset Charges
Long Term Investments
Short Long Term Debt
Cash And Equivalents
Net Invested Capital
Net Working Capital
Depreciation And Amortization
Interest Expense
Total Revenue
Gross Profit
Other Operating Expenses
Operating Income
Ebit
Ebitda
Cost Of Revenue
Total Operating Expenses
Income Before Tax
Total Other Income Expense Net
Income Tax Expense
Selling General Administrative
Research Development
Net Income Applicable To Common Shares
Selling And Marketing Expenses
Net Income From Continuing Ops
Non Recurring
Non Operating Income Net Other
Tax Provision
Net Interest Income
Interest Income
Reconciled Depreciation
Probability Of Bankruptcy
Understanding current and past Johnson Johnson Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Johnson Johnson's financial statements are interrelated, with each one affecting the others. For example, an increase in Johnson Johnson's assets may result in an increase in income on the income statement.
Johnson Johnson competes with PetIQ, Emergent Biosolutions, Neurocrine Biosciences, and Haleon Plc. Johnson Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company was founded in 1886 and is based in New Brunswick, New Jersey. Johnson Johnson operates under Drug ManufacturersGeneral classification in the United States and is traded on New York Stock Exchange. It employs 141700 people.
Foreign Associates
Specialization
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
Johnson Johnson's financial ratios allow both analysts and investors to convert raw data from Johnson Johnson's financial statements into concise, actionable information that can be used to evaluate the performance of Johnson Johnson over time and compare it to other companies across industries.
Comparative valuation techniques use various fundamental indicators to help in determining Johnson Johnson's current stock value. Our valuation model uses many indicators to compare Johnson Johnson value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Johnson Johnson competition to find correlations between indicators driving Johnson Johnson's intrinsic value. More Info.
Johnson Johnson is currently regarded as number one stock in return on equity category among its peers. It is rated second overall in return on asset category among its peers reporting about 0.37 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Johnson Johnson is roughly 2.73 . At this time, Johnson Johnson's Return On Equity is relatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Johnson Johnson by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.
Johnson Johnson Systematic Risk
Johnson Johnson's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Johnson Johnson volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty with a total number of output elements of thirty-one. The Beta measures systematic risk based on how returns on Johnson Johnson correlated with the market. If Beta is less than 0 Johnson Johnson generally moves in the opposite direction as compared to the market. If Johnson Johnson Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Johnson Johnson is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Johnson Johnson is generally in the same direction as the market. If Beta > 1 Johnson Johnson moves generally in the same direction as, but more than the movement of the benchmark.
Johnson Johnson Thematic Clasifications
Johnson Johnson is part of several thematic ideas from Compulsion to Baby Boomer Prospects. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Get More Thematic Ideas
Today, most investors in Johnson Johnson Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Johnson Johnson's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Johnson Johnson growth as a starting point in their analysis.
Johnson Johnson September 19, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Johnson Johnson help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Johnson Johnson. We use our internally-developed statistical techniques to arrive at the intrinsic value of Johnson Johnson based on widely used predictive technical indicators. In general, we focus on analyzing Johnson Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Johnson Johnson's daily price indicators and compare them against related drivers.
Additional Information and Resources on Investing in Johnson Stock
When determining whether Johnson Johnson is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Johnson Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Johnson Johnson Stock. Highlighted below are key reports to facilitate an investment decision about Johnson Johnson Stock:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Johnson Johnson. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For more information on how to buy Johnson Stock please use our How to buy in Johnson Stock guide.You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Johnson Johnson. If investors know Johnson will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Johnson Johnson listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.02)
Dividend Share
4.81
Earnings Share
6.61
Revenue Per Share
35.536
Quarterly Revenue Growth
0.043
The market value of Johnson Johnson is measured differently than its book value, which is the value of Johnson that is recorded on the company's balance sheet. Investors also form their own opinion of Johnson Johnson's value that differs from its market value or its book value, called intrinsic value, which is Johnson Johnson's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Johnson Johnson's market value can be influenced by many factors that don't directly affect Johnson Johnson's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Johnson Johnson's value and its price as these two are different measures arrived at by different means. Investors typically determine if Johnson Johnson is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Johnson Johnson's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.